Imfimzi (durvalumab) has demonstrated a significant benefit in overall survival and in lasting response rates in small cell lung cancer with extended disease in previously … Read more
A new test that analyzes the immune system's response to cancer in its earliest stages has been shown to be able to detect lung cancer … Read more
The researcher of the La Trobe University, in Australia, and associate professor Hamsa Puthalakath is the first scientist to discover why some cancers do not … Read more
September 5 is World Multiple Myeloma Day, the second most frequent hematological tumor in adults, difficult to diagnose and although it still has no cure, … Read more
Treatment with the drug erdafitinib, an inhibitor of FGFR, is effective for advanced urinary tract cancer with alteration in the FGFR 2 or 3 genes. … Read more
Scientists of the Tokyo University of Sciences (Japan) have discovered exactly how circulating free DNA (cfDNA,) is generated, the DNA that is found in small … Read more
Scientists from the Higher Council for Scientific Research (CSIC) have investigated the use of molecular mole cages ’formed by pseudopeptides with the aim of killing … Read more
Head and neck cancer produces 350,000 deaths each year in the world and 85 percent of cases are due to tobacco use, as reported by … Read more
Researchers of the Faculty of Medicine of the University of Virginia (United States) have identified “We have discovered a new non-coding RNA that may be … Read more
The US drug agency (FDA) has approved darolutamide, a non-steroidal androgen receptor antagonist, under the trade name of Nubeqa. The FDA-approved indication is the treatment … Read more